Zogenix Reports Phase 3 Trial Results On Efficacy, Safety Of FINTEPLA In Dravet Syndrome: Data from Second Pivotal Phase 3 Trial Consistent with Results of First Phase 3 Trial in Showing Highly Significant Convulsive Seizure Reduction for FINTEPLA